Introduction: Liaoning Chengda Biological Co., Ltd. ("Chengda Biological" for short) was established in Shenyang in June 2002, taking the opportunity of introducing the international leading vaccine production technology platform. Adhering to the concept of "facing life, only responsibility" and the core values of "honesty and responsibility", the company is committed to the research, development, production and promotion of "international level and domestic leading" biological products, and has built the company into a respected and influential enterprise in the industry. At present, it has the production capacity of more than 40 million doses of rabies vaccine and 65438+ 1 100 million doses of inactivated Japanese encephalitis vaccine for human use.
Legal Representative: Li Ning.
Time of establishment: June 2002-June 65438+July.
Registered capital: 374.8 million yuan.
Industrial and commercial registration number: 2 100004934289
Type of enterprise: other joint stock limited companies (unlisted)
Company address:No. Fang Xin Street 1, Hunnan New District, Shenyang.